Clinical Trial Update: Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ciclosporin for the management of chronic or recurrent erythema nodosum leprosum in leprosy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythema Nodosum Leprosum
• Leprosy

Drugs mentioned

• Ciclosporin (cyclosporine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Leprosy | Phase 2 | Status: COMPLETED